Semi-Annual Consolidated Statement Of Cash Flows

Fuji Pharma Co.,Ltd. - Filing #7610243

Concept As at
2022-03-31
2021-10-01 to
2022-03-31
As at
2021-09-30
As at
2021-03-31
2020-10-01 to
2021-03-31
As at
2020-09-30
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-291,000,000 JPY
4,811,000,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-46,000,000 JPY
-20,000,000 JPY
Income taxes paid
-739,000,000 JPY
-387,000,000 JPY
Net cash provided by (used in) operating activities
-1,076,000,000 JPY
4,405,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,977,000,000 JPY
-1,800,000,000 JPY
Proceeds from sale of property, plant and equipment
4,000,000 JPY
1,000,000 JPY
Proceeds from sale of investment securities
JPY
193,000,000 JPY
Other, net
0 JPY
0 JPY
Net cash provided by (used in) investing activities
-10,296,000,000 JPY
-2,018,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
7,300,000,000 JPY
1,000,000,000 JPY
Repayments of long-term borrowings
-920,000,000 JPY
-836,000,000 JPY
Purchase of treasury shares
JPY
-9,405,000,000 JPY
Dividends paid
-364,000,000 JPY
-467,000,000 JPY
Net cash provided by (used in) financing activities
6,988,000,000 JPY
-3,653,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
160,000,000 JPY
59,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-4,223,000,000 JPY
-1,206,000,000 JPY
Cash and cash equivalents
5,975,000,000 JPY
10,199,000,000 JPY
10,835,000,000 JPY
12,041,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.